397 related articles for article (PubMed ID: 25639866)
1. Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.
Kern D; Regl G; Hofbauer SW; Altenhofer P; Achatz G; Dlugosz A; Schnidar H; Greil R; Hartmann TN; Aberger F
Oncogene; 2015 Oct; 34(42):5341-51. PubMed ID: 25639866
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.
Desch P; Asslaber D; Kern D; Schnidar H; Mangelberger D; Alinger B; Stoecher M; Hofbauer SW; Neureiter D; Tinhofer I; Aberger F; Hartmann TN; Greil R
Oncogene; 2010 Sep; 29(35):4885-95. PubMed ID: 20603613
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.
Beauchamp EM; Ringer L; Bulut G; Sajwan KP; Hall MD; Lee YC; Peaceman D; Ozdemirli M; Rodriguez O; Macdonald TJ; Albanese C; Toretsky JA; Uren A
J Clin Invest; 2011 Jan; 121(1):148-60. PubMed ID: 21183792
[TBL] [Abstract][Full Text] [Related]
4. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.
Schnidar H; Eberl M; Klingler S; Mangelberger D; Kasper M; Hauser-Kronberger C; Regl G; Kroismayr R; Moriggl R; Sibilia M; Aberger F
Cancer Res; 2009 Feb; 69(4):1284-92. PubMed ID: 19190345
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.
Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S
Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023
[TBL] [Abstract][Full Text] [Related]
8. Mouse intraflagellar transport proteins regulate both the activator and repressor functions of Gli transcription factors.
Liu A; Wang B; Niswander LA
Development; 2005 Jul; 132(13):3103-11. PubMed ID: 15930098
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL.
Decker S; Zirlik K; Djebatchie L; Hartmann D; Ihorst G; Schmitt-Graeff A; Herchenbach D; Jumaa H; Warmuth M; Veelken H; Dierks C
Blood; 2012 Jan; 119(4):997-1007. PubMed ID: 22130798
[TBL] [Abstract][Full Text] [Related]
10. Identification of Nedd4 as a novel regulator in Hedgehog signaling.
Luo QF; Chen W; Zhang ST
Chin Med J (Engl); 2012 Nov; 125(21):3851-5. PubMed ID: 23106887
[TBL] [Abstract][Full Text] [Related]
11. Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target.
Zhou J; Zhu G; Huang J; Li L; Du Y; Gao Y; Wu D; Wang X; Hsieh JT; He D; Wu K
Cancer Lett; 2016 Jan; 370(2):313-23. PubMed ID: 26577809
[TBL] [Abstract][Full Text] [Related]
12. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer.
Huang L; Walter V; Hayes DN; Onaitis M
Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612
[TBL] [Abstract][Full Text] [Related]
15. Computational prediction and experimental validation of novel Hedgehog-responsive enhancers linked to genes of the Hedgehog pathway.
Gurdziel K; Vogt KR; Schneider G; Richards N; Gumucio DL
BMC Dev Biol; 2016 Feb; 16():4. PubMed ID: 26912062
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling.
Riobo NA; Haines GM; Emerson CP
Cancer Res; 2006 Jan; 66(2):839-45. PubMed ID: 16424016
[TBL] [Abstract][Full Text] [Related]
17. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
Pandolfi S; Montagnani V; Lapucci A; Stecca B
Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
[TBL] [Abstract][Full Text] [Related]
18. The zebrafish iguana locus encodes Dzip1, a novel zinc-finger protein required for proper regulation of Hedgehog signaling.
Sekimizu K; Nishioka N; Sasaki H; Takeda H; Karlstrom RO; Kawakami A
Development; 2004 Jun; 131(11):2521-32. PubMed ID: 15115751
[TBL] [Abstract][Full Text] [Related]
19. A dynamic Gli code interprets Hh signals to regulate induction, patterning, and endocrine cell specification in the zebrafish pituitary.
Devine CA; Sbrogna JL; Guner B; Osgood M; Shen MC; Karlstrom RO
Dev Biol; 2009 Feb; 326(1):143-54. PubMed ID: 19056374
[TBL] [Abstract][Full Text] [Related]
20. Yeast-based assay identifies novel Shh/Gli target genes in vertebrate development.
Milla LA; Cortés CR; Hodar C; Oñate MG; Cambiazo V; Burgess SM; Palma V
BMC Genomics; 2012 Jan; 13():2. PubMed ID: 22214306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
